Clinical Trials

Showing 81 - 100 of 444 trials
Titlesort icon Investigator Disease(s)
A Phase I Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors
[Protocol 08-091]
Dunkel, Ira
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase I Study of the Hu3F8 Antibody plus GM-CSF in Patients with Relapsed/Refractory Neuroblastoma
[Protocol 12-230]
Kushner, Brian
  • Neuroblastoma
A Phase I Study of the NY-ESO-1 Vaccine plus Ipilimumab in Patients with Inoperable or Metastatic Melanoma
[Protocol 12-253]
Wolchok, Jedd
  • Melanoma
A Phase I Study of the Treatment of Beta-Thalassemia with a Gene Transfer Approach
[Protocol 10-164]
Boulad, Farid
  • Hematology
    • Hematologic Disorders
A Phase I Study of Tigecycline in Patients with Relapsed or Refractory Acute Myeloid Leukemia
[Protocol 12-148]
Tallman, Martin
  • Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
A Phase I Study of Topical Calcitriol (Compound 31543) to Prevent Hair Loss in Women Receiving Paclitaxel for Advanced Breast Cancer
[Protocol 11-205]
Lacouture, Mario
  • Breast Cancer
A Phase I Study of TRC105 plus Bevacizumab in Patients with Recurrent Glioma
[Protocol 12-217]
Omuro, Antonio
  • Brain Tumors, Primary
    • Gliomas
A Phase I Study of Veliparib Given with Radiation Therapy to the Chest Wall and Lymph Nodes in Patients with Inflammatory or Recurrent Breast Cancer
[Protocol 12-215]
Ho, Alice
A Phase I Study of Vemurafenib in Adolescents with Inoperable Stage IIIC/IV Melanoma with V600 BRAF Mutations
[Protocol 11-198]
Pratilas, Christine
  • Melanoma
A Phase I Study of VTX-2337 Plus Doxil in Patients with Recurrent or Persistent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 11-110]
Bell-McGuinn, Katherine
  • Ovarian Cancer
A Phase I Study of Whole Brain Radiation Therapy plus Sorafenib for Patients with Breast Cancer Brain Metastases
[Protocol 12-046]
Seidman, Andrew
  • Brain Tumors, Metastatic
  • Breast Cancer
A Phase I Study of WT1-Sensitized T cells for Residual or Relapsed Leukemia after Allogeneic Hematopoietic Progenitor Cell Transplantation
[Protocol 07-055]
O'Reilly, Richard
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Myelodysplastic Syndrome
A Phase I Study of WT1-Specific Donor-Derived T Cells in Patients with Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia after T-Cell-Depleted Allogeneic Stem Cell Transplantation
[Protocol 12-175]
Koehne, Guenther
  • Hematology
    • Multiple Myeloma
A Phase I Study of WT1-Specific T Cells for the Treatment of Patients with Advanced Ovarian, Primary Peritoneal, and Fallopian Tube Cancers
[Protocol 06-155]
O'Cearbhaill, Roisin
  • Ovarian Cancer
A Phase I Study of Xenogeneic CD20 DNA Vaccination in Patients with B-cell Lymphoma
[Protocol 07-100]
Palomba, M. Lia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I Study of Yttrium-90 Attached to Chimeric Monoclonal Antibody CG250 in Patients with Advanced Renal Cancer
[Protocol 05-031]
Larson, Steven
  • Kidney Cancer
A Phase I Trial of a New Vaccine (Globo-H-GM2-sTn-TF-Tn) for Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission
[Protocol 09-184]
Sabbatini, Paul
  • Ovarian Cancer
A Phase I Trial of a Trivalent Vaccine with Escalating Doses of the Immunological Adjuvant OPT-821 Plus Oral ß-Glucan for High-Risk Neuroblastoma
[Protocol 05-075]
Kushner, Brian
  • Neuroblastoma
A Phase I Trial of B-Cell Acute Lymphoblastic Leukemia Treated with Autologous T Cells Gene-Targeted to the B-Cell Antigen CD19
[Protocol 09-114]
Davila, Marco
  • Leukemia
    • Acute Lymphoblastic Leukemia
A Phase I Trial of Gemcitabine and Split-Dose Cisplatin plus Everolimus in Patients with Advanced Urothelial Cancer
[Protocol 10-106]
Bajorin, Dean
  • Bladder Cancer